JS Link, Inc. (KOSDAQ: A127120)
Health Care · Biotechnology · KR
₩28,750.00
-1.54% today · +23.7% 1Y
JS Link, Inc. (KOSDAQ: A127120) operates in the Biotechnology industry within the Health Care sector. The company is valued at $743.20M.
Over the last twelve months the share price has gained 23.7%, trading between 13.86K and 49.90K.
Tweenvest scores JS Link, Inc. across four factors: quality 58/100, value 60/100. Its strongest factor is value.
A127120 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $743.20M
- Revenue (TTM)
- $14.71M
- P/E
- —
- EPS
- -530.19
- Dividend yield
- —
- Beta (5Y)
- 0.58
- 52-week high
- ₩49,900.00
- 52-week low
- ₩13,860.00
- Avg volume (3M)
- —
- Shares outstanding
- 34.75M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Inventiva S.A.ENXTPA: IVA | $756.65M | €2.86 | -9.06% |
| Annexon, Inc.NasdaqGS: ANNX | $750.73M | $3.96 | -1.49% |
| Verastem, Inc.NasdaqCM: VSTM | $747.15M | $8.25 | -1.55% |
| Gyre Therapeutics, Inc.NasdaqCM: GYRE | $746.48M | $6.87 | -2.49% |
| HanchorBio Inc.TWSE: 7827 | $739.81M | NT$169.00 | +1.20% |
| Solid Biosciences Inc.NasdaqGS: SLDB | $736.64M | $6.71 | -2.33% |
| 4D Molecular Therapeutics, Inc.NasdaqGS: FDMT | $718.17M | $13.00 | -2.48% |
| ChemPartner PharmaTech Co.,Ltd.SZSE: 300149 | $713.97M | CN¥9.47 | -4.34% |
Figures last refreshed Oct 11, 2026.